Clinical Trial

Super-Rehab: a Novel Approach to Treat Atrial Fibrillation

Study acronym: SuRe-AF
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 12, 2025 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study proposes to evaluate the effectiveness of a novel lifestyle intervention (Super Rehab), in addition to standard care, for patients with symptomatic atrial fibrillation (AF) requiring rhythm control strategy who are overweight. As the main driver behind the selection of a rhythm-control strategy for patients with AF, the primary outcome will be an improvement in AF-related symptoms with Super Rehab versus Usual Care only. Secondary outcomes will include the burden of AF, biochemical and cardiac functional and structural changes, and markers of quality-of-life and health resource use.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-10-26; most recent amendment 2025-08-06.
Status change: Recruiting → Active, Not Recruiting 2025-08-06
Status change: Not Yet Recruiting → Recruiting 2023-09-07
Trial Details
NCT Number NCT05596175
Lead Sponsor Royal United Hospitals Bath NHS Foundation Trust
Collaborators: University of Bath, University of Oxford, Biotronik SE & Co. KG, RUHX (Official NHS Charity for RUH Bath)
Conditions Atrial Fibrillation, Overweight and Obesity
Enrollment 36 participants
Start Date 2023-04-03
Primary Completion 2025-11-30 (estimated)
Study Completion 2025-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-12